{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T03:06:18Z","timestamp":1782529578506,"version":"3.54.5"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.intimp.2022.109370","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:47:32Z","timestamp":1666918052000},"page":"109370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"PA","title":["AKT\/GSK3\u03b2\/NFATc1 and ROS signal axes are involved in AZD1390-mediated inhibitory effects on osteoclast and OVX-induced osteoporosis"],"prefix":"10.1016","volume":"113","author":[{"given":"Shuyue","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuangang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansi","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiake","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10169","key":"10.1016\/j.intimp.2022.109370_b0005","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","article-title":"Osteoporosis","volume":"393","author":"Compston","year":"2019","journal-title":"The Lancet"},{"issue":"9773","key":"10.1016\/j.intimp.2022.109370_b0010","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","article-title":"Osteoporosis: now and the future","volume":"377","author":"Rachner","year":"2011","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2022.109370_b0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00774-020-01153-7","article-title":"RANKL as a target for the treatment of osteoporosis","volume":"39","author":"Matsumoto","year":"2021","journal-title":"J. Bone Miner. Metab."},{"issue":"21","key":"10.1016\/j.intimp.2022.109370_b0020","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1182\/bloodadvances.2021004552","article-title":"Novel population of human monocyte and osteoclast progenitors from pluripotent stem cells and peripheral blood","volume":"5","author":"Root","year":"2021","journal-title":"Blood Adv."},{"issue":"8","key":"10.1016\/j.intimp.2022.109370_b0025","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.molmed.2014.06.001","article-title":"Osteoclasts: more than 'bone eaters'","volume":"20","author":"Charles","year":"2014","journal-title":"Trends Mol. Med."},{"issue":"10","key":"10.1016\/j.intimp.2022.109370_b0030","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1002\/jcp.26596","article-title":"MicroRNA-224 suppresses osteoblast differentiation by inhibiting SMAD4","volume":"233","author":"Luo","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109370_b0035","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1089\/ten.teb.2016.0454","article-title":"Osteoblast differentiation and bone matrix formation in vivo and in vitro","volume":"23","author":"Blair","year":"2017","journal-title":"Tissue Eng Part B Rev"},{"key":"10.1016\/j.intimp.2022.109370_b0040","first-page":"515","article-title":"Management of osteoporosis with calcitriol in elderly Chinese patients: a systematic review","volume":"9","author":"Liao","year":"2014","journal-title":"Clin. Interv. Aging"},{"issue":"4","key":"10.1016\/j.intimp.2022.109370_b0045","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/neuonc\/noaa238","article-title":"Brain exposure of the ATM inhibitor AZD1390 in humans-a positron emission tomography study","volume":"23","author":"Jucaite","year":"2021","journal-title":"Neuro Oncol"},{"issue":"20","key":"10.1016\/j.intimp.2022.109370_b0050","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1080\/15384101.2015.1084205","article-title":"ATM serine-1981 phosphorylation is a plausible biomarker","volume":"14","author":"Bakkenist","year":"2015","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.intimp.2022.109370_b0055","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41577-019-0135-6","article-title":"At the intersection of DNA damage and immune responses","volume":"19","author":"Bednarski","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2022.109370_b0060","doi-asserted-by":"crossref","first-page":"e0244060","DOI":"10.1371\/journal.pone.0244060","article-title":"ATM inhibition enhances Auranofin-induced oxidative stress and cell death in lung cell lines","volume":"15","author":"Ehrenfeld","year":"2020","journal-title":"PLoS ONE"},{"issue":"167","key":"10.1016\/j.intimp.2022.109370_b0065","doi-asserted-by":"crossref","first-page":"p. pe17","DOI":"10.1126\/scisignal.2001959","article-title":"ATM is a redox sensor linking genome stability and carbon metabolism","volume":"4","author":"Kruger","year":"2011","journal-title":"Sci Signal"},{"key":"10.1016\/j.intimp.2022.109370_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.07.002","article-title":"ATM in DNA repair in cancer","volume":"203","author":"Jin","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2022.109370_b0075","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.7150\/thno.30206","article-title":"Pseurotin A inhibits osteoclastogenesis and prevents ovariectomized-induced bone loss by suppressing reactive oxygen species","volume":"9","author":"Chen","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2022.109370_b0080","first-page":"89","article-title":"Ovariectomized rat model of osteoporosis: a practical guide","volume":"19","author":"Yousefzadeh","year":"2020","journal-title":"EXCLI J"},{"key":"10.1016\/j.intimp.2022.109370_b0085","article-title":"Sesamolin protects mice from ovariectomized bone loss by inhibiting osteoclastogenesis and RANKL-mediated NF-kappaB and MAPK signaling pathways","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109370_b0090","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/cdd.2011.88","article-title":"Autophagy promotes survival of retinal ganglion cells after optic nerve axotomy in mice","volume":"19","author":"Rodriguez-Muela","year":"2012","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.intimp.2022.109370_b0095","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbrc.2016.05.019","article-title":"Osteoclast function and bone-resorbing activity: An overview","volume":"476","author":"Soysa","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.intimp.2022.109370_b0100","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1111\/jcmm.15229","article-title":"Triptolide prevents bone loss via suppressing osteoclastogenesis through inhibiting PI3K-AKT-NFATc1 pathway","volume":"24","author":"Cui","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"3","key":"10.1016\/j.intimp.2022.109370_b0105","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1182\/blood-2004-09-3662","article-title":"A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation","volume":"106","author":"Lee","year":"2005","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.intimp.2022.109370_b0110","doi-asserted-by":"crossref","first-page":"e12882","DOI":"10.1111\/cpr.12882","article-title":"Schisandrin A restrains osteoclastogenesis by inhibiting reactive oxygen species and activating Nrf2 signalling","volume":"53","author":"Ni","year":"2020","journal-title":"Cell Prolif."},{"issue":"2","key":"10.1016\/j.intimp.2022.109370_b0115","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1096\/fj.201600826R","article-title":"RANKL induces Bach1 nuclear import and attenuates Nrf2-mediated antioxidant enzymes, thereby augmenting intracellular reactive oxygen species signaling and osteoclastogenesis in mice","volume":"31","author":"Kanzaki","year":"2017","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.intimp.2022.109370_b0120","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/13697137.2018.1551347","article-title":"Hormone replacement therapy and prevention of chronic conditions","volume":"22","author":"Gambacciani","year":"2019","journal-title":"Climacteric"},{"issue":"5","key":"10.1016\/j.intimp.2022.109370_b0125","doi-asserted-by":"crossref","first-page":"e392","DOI":"10.1002\/ctm2.392","article-title":"A novel RANKL-targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species","volume":"11","author":"Hong","year":"2021","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.109370_b0130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","article-title":"An overview and management of osteoporosis","volume":"4","author":"Sozen","year":"2017","journal-title":"Eur. J. Rheumatol."},{"issue":"20","key":"10.1016\/j.intimp.2022.109370_b0135","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1001\/jama.2019.15781","article-title":"Bisphosphonates for Postmenopausal Osteoporosis","volume":"322","author":"Ensrud","year":"2019","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.intimp.2022.109370_b0140","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.trecan.2021.06.002","article-title":"Targeting the replication stress response through synthetic lethal strategies in cancer medicine","volume":"7","author":"Ngoi","year":"2021","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2022.109370_b0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00774-020-01162-6","article-title":"Osteoclast differentiation by RANKL and OPG signaling pathways","volume":"39","author":"Udagawa","year":"2021","journal-title":"J. Bone Miner. Metab."},{"issue":"4","key":"10.1016\/j.intimp.2022.109370_b0150","first-page":"308","article-title":"Advances in bone biology: the osteoclast","volume":"17","author":"Roodman","year":"1996","journal-title":"Endocr. Rev."},{"issue":"11","key":"10.1016\/j.intimp.2022.109370_b0155","first-page":"3003","article-title":"Promoter hypermethylation of the ATM gene as a novel biomarker for breast cancer","volume":"18","author":"Begam","year":"2017","journal-title":"Asian Pac. J. Can. Prev."},{"issue":"5","key":"10.1016\/j.intimp.2022.109370_b0160","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.drudis.2019.01.015","article-title":"Building on the success of osimertinib: achieving CNS exposure in oncology drug discovery","volume":"24","author":"Colclough","year":"2019","journal-title":"Drug Discov Today"},{"issue":"2","key":"10.1016\/j.intimp.2022.109370_b0165","first-page":"783","article-title":"PI3K\/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review)","volume":"19","author":"Xie","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"Pt 15","key":"10.1016\/j.intimp.2022.109370_b0170","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1242\/jcs.00609","article-title":"The phosphoinositide (PI) 3-kinase family","volume":"116","author":"Foster","year":"2003","journal-title":"J. Cell Sci."},{"issue":"5","key":"10.1016\/j.intimp.2022.109370_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118664","article-title":"Glycogen synthase kinase-3 signaling in Alzheimer's disease","volume":"1867","author":"Lauretti","year":"2020","journal-title":"Biochim. Biophys. Acta, Mol. Cell. Res."},{"key":"10.1016\/j.intimp.2022.109370_b0180","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.brainres.2010.03.007","article-title":"Minocycline treatment reduces white matter damage after excitotoxic striatal injury","volume":"1329","author":"Guimaraes","year":"2010","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.intimp.2022.109370_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118659","article-title":"GSK-3beta in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer","volume":"1867","author":"Lin","year":"2020","journal-title":"Biochim. Biophys. Acta, Mol. Cell. Res."},{"issue":"1","key":"10.1016\/j.intimp.2022.109370_b0190","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13058-019-1125-0","article-title":"GSK3beta regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer","volume":"21","author":"Vijay","year":"2019","journal-title":"Breast Can. Res."},{"issue":"1","key":"10.1016\/j.intimp.2022.109370_b0195","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4161\/15384101.2014.973330","article-title":"ATM regulates cell fate choice upon p53 activation by modulating mitochondrial turnover and ROS levels","volume":"14","author":"Sullivan","year":"2015","journal-title":"Cell Cycle"},{"issue":"8","key":"10.1016\/j.intimp.2022.109370_b0200","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/nar\/gkp100","article-title":"Oxidative stress induces degradation of mitochondrial DNA","volume":"37","author":"Shokolenko","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.intimp.2022.109370_b0205","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/jbmr.2974","article-title":"SOD2 and Sirt3 control osteoclastogenesis by regulating mitochondrial ROS","volume":"32","author":"Kim","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"8","key":"10.1016\/j.intimp.2022.109370_b0210","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1359\/JBMR.050324","article-title":"Thapsigargin modulates osteoclastogenesis through the regulation of RANKL-induced signaling pathways and reactive oxygen species production","volume":"20","author":"Yip","year":"2005","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.intimp.2022.109370_b0215","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.yexcr.2004.07.035","article-title":"Reactive oxygen species mediate RANK signaling in osteoclasts","volume":"301","author":"Ha","year":"2004","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.intimp.2022.109370_b0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20455\/ros.2016.803","article-title":"Defining ROS in biology and medicine","volume":"1","author":"Li","year":"2016","journal-title":"React Oxyg Species (Apex)"},{"issue":"10","key":"10.1016\/j.intimp.2022.109370_b0225","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Curr. Biol."},{"issue":"7","key":"10.1016\/j.intimp.2022.109370_b0230","doi-asserted-by":"crossref","first-page":"e10080","DOI":"10.1002\/jbm4.10080","article-title":"CSF-1 in osteocytes inhibits Nox4-mediated oxidative stress and promotes normal bone homeostasis","volume":"4","author":"Werner","year":"2020","journal-title":"JBMR Plus"},{"issue":"14","key":"10.1016\/j.intimp.2022.109370_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20143576","article-title":"Reactive oxygen species in osteoclast differentiation and possible pharmaceutical targets of ROS-mediated osteoclast diseases","volume":"20","author":"Agidigbi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2022.109370_b0240","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/s41598-020-80536-2","article-title":"Lactobacillus rhamnosus attenuates bone loss and maintains bone health by skewing Treg-Th17 cell balance in Ovx mice","volume":"11","author":"Sapra","year":"2021","journal-title":"Sci. Rep."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922008542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922008542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:55:37Z","timestamp":1761587737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922008542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":48,"alternative-id":["S1567576922008542"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109370","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AKT\/GSK3\u03b2\/NFATc1 and ROS signal axes are involved in AZD1390-mediated inhibitory effects on osteoclast and OVX-induced osteoporosis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109370","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109370"}}